These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Amyloid-beta oligomers increase the localization of prion protein at the cell surface. Caetano FA; Beraldo FH; Hajj GN; Guimaraes AL; Jürgensen S; Wasilewska-Sampaio AP; Hirata PH; Souza I; Machado CF; Wong DY; De Felice FG; Ferreira ST; Prado VF; Rylett RJ; Martins VR; Prado MA J Neurochem; 2011 May; 117(3):538-53. PubMed ID: 21352228 [TBL] [Abstract][Full Text] [Related]
5. Cellular prion protein as a therapeutic target in Alzheimer's disease. Laurén J J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943 [TBL] [Abstract][Full Text] [Related]
6. The association between prion proteins and Aβ₁₋₄₂ oligomers in cytotoxicity and apoptosis. Hyeon JW; Kim SY; Park JS; Choi BY; Lee SM; Ju YR; An SS; Kim CK Biochem Biophys Res Commun; 2012 Jul; 424(2):214-20. PubMed ID: 22743555 [TBL] [Abstract][Full Text] [Related]
7. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease. Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains. Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334 [TBL] [Abstract][Full Text] [Related]
9. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice. Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092 [TBL] [Abstract][Full Text] [Related]
10. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance. Smith LM; Kostylev MA; Lee S; Strittmatter SM J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106 [TBL] [Abstract][Full Text] [Related]
11. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease. Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981 [TBL] [Abstract][Full Text] [Related]
12. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates. Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway. Chen RJ; Chang WW; Lin YC; Cheng PL; Chen YR ACS Chem Neurosci; 2013 Sep; 4(9):1287-96. PubMed ID: 23805846 [TBL] [Abstract][Full Text] [Related]
14. Soluble Prion Peptide 107-120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer's Disease. Rezvani Boroujeni E; Hosseini SM; Fani G; Cecchi C; Chiti F Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019683 [TBL] [Abstract][Full Text] [Related]
15. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures. Bate C; Williams A Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466 [TBL] [Abstract][Full Text] [Related]
17. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Balducci C; Beeg M; Stravalaci M; Bastone A; Sclip A; Biasini E; Tapella L; Colombo L; Manzoni C; Borsello T; Chiesa R; Gobbi M; Salmona M; Forloni G Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2295-300. PubMed ID: 20133875 [TBL] [Abstract][Full Text] [Related]
18. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. Chung E; Ji Y; Sun Y; Kascsak RJ; Kascsak RB; Mehta PD; Strittmatter SM; Wisniewski T BMC Neurosci; 2010 Oct; 11():130. PubMed ID: 20946660 [TBL] [Abstract][Full Text] [Related]
19. The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers. Younan ND; Sarell CJ; Davies P; Brown DR; Viles JH FASEB J; 2013 May; 27(5):1847-58. PubMed ID: 23335053 [TBL] [Abstract][Full Text] [Related]
20. Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice. Bobkova NV; Medvinskaya NI; Kamynina AV; Aleksandrova IY; Nesterova IV; Samokhin AN; Koroev DO; Filatova MP; Nekrasov PV; Abramov AY; Leonov SV; Volpina OM Neurobiol Learn Mem; 2014 Jan; 107():50-64. PubMed ID: 24239620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]